1834 Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.23M Sell
36,351
-2,583
-7% -$602K 1.05% 25
2026
Q1
$9.52M Sell
38,934
-622
-2% -$145K 1.19% 26
2025
Q4
$8.19M Sell
39,556
-2,191
-5% -$433K 1.03% 27
2025
Q3
$7.74M Sell
41,747
-894
-2% -$153K 0.95% 29
2025
Q2
$6.51M Sell
42,641
-841
-2% -$129K 0.82% 37
2025
Q1
$7.21M Sell
43,482
-2,256
-5% -$353K 0.93% 30
2024
Q4
$6.61M Sell
45,738
-2,459
-5% -$381K 0.84% 34
2024
Q3
$7.81M Sell
48,197
-4,534
-9% -$722K 0.91% 32
2024
Q2
$7.71M Sell
52,731
-750
-1% -$112K 0.93% 29
2024
Q1
$8.46M Sell
53,481
-5,732
-10% -$912K 1.01% 24
2023
Q4
$9.28M Sell
59,213
-2,329
-4% -$357K 1.11% 20
2023
Q3
$9.59M Sell
61,542
-1,905
-3% -$314K 1.19% 17
2023
Q2
$10.5M Sell
63,447
-1,407
-2% -$227K 1.25% 18
2023
Q1
$10.1M Buy
64,854
+2,382
+4% +$385K 1.2% 19
2022
Q4
$11M Sell
62,472
-305
-0.5% -$52.7K 1.58% 15
2022
Q3
$10.3M Buy
62,777
+484
+0.8% +$81.9K 1.53% 18
2022
Q2
$11.1M Sell
62,293
-1,080
-2% -$192K 1.56% 17
2022
Q1
$11.2M Sell
63,373
-3,833
-6% -$652K 1.38% 21
2021
Q4
$11.5M Buy
67,206
+923
+1% +$151K 1.3% 23
2021
Q3
$10.7M Buy
66,283
+51
+0.1% +$8.7K 1.31% 21
2021
Q2
$10.9M Buy
66,232
+1,082
+2% +$179K 1.32% 21
2021
Q1
$10.7M Sell
65,150
-4,165
-6% -$674K 1.39% 20
2020
Q4
$10.9M Sell
69,315
-288
-0.4% -$42.5K 1.45% 19
2020
Q3
$10.4M Buy
69,603
+552
+0.8% +$81.7K 1.51% 18
2020
Q2
$9.71M Buy
69,051
+4,295
+7% +$626K 1.54% 18
2020
Q1
$8.49M Sell
64,756
-265
-0.4% -$37.6K 1.61% 16
2019
Q4
$9.48M Sell
65,021
-7,030
-10% -$954K 1.45% 22
2019
Q3
$9.32M Buy
72,051
+559
+0.8% +$73.6K 1.35% 23
2019
Q2
$9.96M Sell
71,492
-702
-1% -$97.2K 1.5% 18
2019
Q1
$10.1M Sell
72,194
-1,306
-2% -$175K 1.54% 17
2018
Q4
$9.49M Buy
73,500
+622
+0.9% +$86.8K 1.59% 14
2018
Q3
$10.1M Sell
72,878
-373
-0.5% -$49.6K 1.47% 18
2018
Q2
$8.89M Buy
73,251
+1,287
+2% +$161K 1.39% 20
2018
Q1
$9.22M Buy
71,964
+9,844
+16% +$1.33M 1.58% 17
2017
Q4
$8.68M Buy
62,120
+1,649
+3% +$230K 1.37% 23
2017
Q3
$7.86M Sell
60,471
-5,651
-9% -$749K 1.47% 21
2017
Q2
$8.75M Sell
66,122
-7,556
-10% -$964K 1.65% 13
2017
Q1
$9.18M Sell
73,678
-1,127
-2% -$135K 1.76% 11
2016
Q4
$8.62M Buy
74,805
+3,094
+4% +$357K 1.74% 14
2016
Q3
$8.47M Sell
71,711
-1,017
-1% -$123K 1.84% 9
2016
Q2
$8.82M Buy
72,728
+59
+0.1% +$6.7K 1.91% 8
2016
Q1
$7.86M Sell
72,669
-788
-1% -$81.6K 1.8% 9
2015
Q4
$7.54M Buy
73,457
+1,763
+2% +$177K 1.77% 9
2015
Q3
$6.69M Buy
71,694
+9,848
+16% +$953K 1.66% 11
2015
Q2
$6.03M Buy
61,846
+3,013
+5% +$302K 1.65% 17
2015
Q1
$5.92M Buy
58,833
+401
+0.7% +$40.8K 1.61% 17
2014
Q4
$6.11M Buy
58,432
+1,208
+2% +$127K 1.69% 14
2014
Q3
$6.1M Sell
57,224
-526
-0.9% -$54.6K 1.68% 11
2014
Q2
$6.04M Sell
57,750
-730
-1% -$73.8K 1.64% 12
2014
Q1
$5.74M Buy
58,480
+908
+2% +$84.2K 1.68% 12
2013
Q4
$5.27M Buy
57,572
+478
+0.8% +$44.1K 1.55% 16
2013
Q3
$4.95M Sell
57,094
-491
-0.9% -$44K 1.62% 17
2013
Q2
$4.94M Buy
+57,585
New +$4.89M 1.7% 12

Other funds holding JNJ

1834 Investment Advisors's JNJ Position: Q2 2026 in Review

1834 Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 6.6% in Q2 2026, selling an estimated $602K and leaving 36,351 shares worth $9.23M. The position accounts for 1.05% of the portfolio, ranked #25.

1834 Investment Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.5M in Q4 2021. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • 1834 Investment Advisors held 36,351 shares of Johnson & Johnson worth $9.23M as of Q2 2026.
  • 1834 Investment Advisors sold 2,583 Johnson & Johnson shares in Q2 2026, an estimated $602K.
  • Johnson & Johnson made up 1.05% of 1834 Investment Advisors's portfolio in Q2 2026, its #25 holding.
  • 1834 Investment Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1834 Investment Advisors's Johnson & Johnson position peaked at $11.5M in Q4 2021.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on 1834 Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.